World's Best Scientists 2026 revealed!
Mark J. Federspiel

Mark J. Federspiel

D-Index & Metrics

Microbiology

D-Index
44
Citations
6633
World Ranking
5167
National Ranking
1980

Mark J. Federspiel publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mark J. Federspiel sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 107 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mark J. Federspiel D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark J. Federspiel sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 44 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mark J. Federspiel is affiliated with the Mayo Clinic in the United States and conducts research primarily within the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their work spans various subfields including Genetics, Immunology, Epidemiology, Molecular Biology, and Ophthalmology.

The scientist's research topics focus prominently on virus-based gene therapy, immunotherapy and immune responses, interferon and immune responses, ocular oncology and treatments, virology and viral diseases, respiratory viral infections, and herpesvirus infections and treatments.

Recent publications by Mark J. Federspiel include:

  • Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial (2024), Nature Communications
  • A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses (2023), Frontiers in Immunology
  • Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene (2022), Molecular Therapy - Methods & Clinical Development
  • Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer (2022), Molecular Therapy - Oncolytics
  • Live Attenuated Measles Virus Vaccine Expressing Helicobacter pylori Heat Shock Protein A (2020), Molecular Therapy - Oncolytics

Frequent publication venues for Federspiel include:

  • Molecular Therapy - Oncolytics
  • Nature Communications
  • Frontiers in Immunology
  • Molecular Therapy - Methods & Clinical Development
  • Journal of Medicinal Chemistry

Collaboration plays a significant role in their research output, with common coauthors being Evanthia Galanis, Kimberly Viker, Ianko Iankov, Cheyne Kurokawa, and Steven I. Robinson.

Best Publications

  • Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

    Evanthia Galanis;Lynn C. Hartmann;William A. Cliby;Harry J. Long

  • Extended analysis of the in vitro tropism of porcine endogenous retrovirus.

    Carolyn A. Wilson;Susan Wong;Matthew VanBrocklin;Mark J. Federspiel

  • The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors.

    Janet Schaefer-Klein;Iris Givol;Eugene V. Barsov;Jeannette M. Whitcomb

  • Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer.

    Maria P. De Miguel;Linzhao Cheng;Eric C. Holland;Mark J. Federspiel

  • A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors

    Mark J. Federspiel;Paul Bates;John A. T. Young;Harold E. Varmus;Harold E. Varmus

  • Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer

    Evanthia Galanis;Pamela J. Atherton;Matthew J. Maurer;Keith L Knutson

  • Infected cell carriers: A new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy

    Ianko D Iankov;Boris Blechacz;Chunsheng Liu;Jeffrey D Schmeckpeper

  • Retroviral gene delivery

    Mark J. Federspiel;Stephen H. Hughes

  • Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide

    Myers Rm;Greiner Sm;Harvey Me;Griesmann G

  • Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma.

    Angela Dispenzieri;Caili Tong;Betsy LaPlant;Martha Q. Lacy

  • Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer

    Emily K. Mader;Greg Butler;Sean C. Dowdy;Andrea Mariani

  • Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma

    Boris Blechacz;Patrick L. Splinter;Suzanne Greiner;Rae Myers

  • Dual Therapy of Ovarian Cancer Using Measles Viruses Expressing Carcinoembryonic Antigen and Sodium Iodide Symporter

    Kosei Hasegawa;Linh Pham;Michael K. O'Connor;Mark J. Federspiel

  • Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

    Pavlos Msaouel;Mateusz Opyrchal;Angela Dispenzieri;Kah Whye Peng

  • Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

    Manish R. Patel;Blake A. Jacobson;Yan Ji;Jeremy Drees

  • Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

    Cory Allen;Mateusz Opyrchal;Ileana Aderca;Mark A. Schroeder

  • Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma

    Candice L. Willmon;Vassiliki Saloura;Zvi G. Fridlender;Phonphimon Wongthida

  • Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses

    Peng Kw;Myers R;Greenslade A;Mader E

  • Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth

    Hooi Tin Ong;Mark J. Federspiel;Chang M. Guo;London Lucien Ooi

  • Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas

    Rae Myers;Mary Harvey;Timothy J. Kaufmann;Suzanne M. Greiner

  • Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-β for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines Potential Efficacy

    Vassiliki Saloura;Liang Chuan S. Wang;Zvi G. Fridlender;Jing Sun

Frequent Co-Authors

Kah Whye Peng
Kah Whye Peng Mayo Clinic
Evanthia Galanis
Evanthia Galanis Mayo Clinic
Glen N. Barber
Glen N. Barber University of Miami
Kent R. Bailey
Kent R. Bailey Mayo Clinic
David Dingli
David Dingli Mayo Clinic
Martha Q. Lacy
Martha Q. Lacy Mayo Clinic
Morie A. Gertz
Morie A. Gertz Mayo Clinic
John C. Morris
John C. Morris Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, related online degrees offer diverse career opportunities in the health and information sectors. Many aspiring professionals explore certification through a cpc program. This credential opens doors to roles in medical billing and coding, which play a critical role in healthcare administration and ensuring accurate medical records.

Another promising path is health information management. Jobs in this field require expertise in managing patient data and healthcare systems efficiently. Understanding the scope of health information management jobs salary can help students make informed decisions about their career trajectories.

For those seeking quality education options, enrolling in one of the best cahiim accredited him programs online can provide the necessary training and credentials required to advance in this sector.

Additionally, students aiming for quicker entry into the workforce might consider fastest online medical billing and coding certificate programs. These accelerated programs offer a fast track to certification and are ideal for those seeking to start their careers without delay.

Best Scientists Citing Mark J. Federspiel

Trending Scientists

Recently Published Articles